Compare
CACI International Inc vs Science Applications International Corp vs Parsons Corp vs Leidos Holdings, Inc.
| Latest fiscal year | CACI International Inc CACI | Science Applications International Corp SAIC | Parsons Corp PSN | Leidos Holdings, Inc. LDOS |
|---|---|---|---|---|
| Year ended | 2026-06-30 | 2026-01-30 | 2025-12-31 | 2026-01-02 |
| Revenue | $9.57B | $7.26B | $6.36B | $17.17B |
| Revenue growth (YoY) | +10.9% | -2.9% | -5.7% | +3.1% |
| Gross margin | n/a | 12.0% (computed) | 22.5% (computed) | 18.0% (computed) |
| Operating margin | 9.6% | 7.2% | 6.6% | 12.3% |
| Net margin | 5.6% | 4.9% | 3.8% | 8.4% |
| Net income | $535.81M | $358.00M | $241.14M | $1.45B |
| EPS (Diluted) | $24.16 | $7.70 | $2.20 | $11.14 |
| Operating cash flow | $886.71M | $609.00M | $478.38M | $1.75B |
| Free cash flow | $780.06M | $577.00M | $410.41M | $1.62B |
| Cash & equivalents | $191.76M | $182.00M | $466.39M | $1.11B |
| Total assets | $11.82B | $5.35B | $5.77B | $13.49B |
| Total liabilities | $7.36B | n/a | $3.00B | $8.53B |
| Shareholders' equity | $4.46B | $1.50B | $2.77B | $4.92B |
| Return on year-end equity | 12.0% | 23.9% | 8.7% | 29.5% |
| Shares outstanding | 22.10M | 44.00M | 56.10M | 126.38M |
Revenue, most recent five fiscal years
| Fiscal year | CACI International Inc | Science Applications International Corp | Parsons Corp | Leidos Holdings, Inc. |
|---|---|---|---|---|
| Latest | $9.57B Ended 2026-06-30 | $7.26B Ended 2026-01-30 | $6.36B Ended 2025-12-31 | $17.17B Ended 2026-01-02 |
| 1 year earlier | $8.63B Ended 2025-06-30 | $7.48B Ended 2025-01-31 | $6.75B Ended 2024-12-31 | $16.66B Ended 2025-01-03 |
| 2 years earlier | $7.66B Ended 2024-06-30 | $7.44B Ended 2024-02-02 | $5.44B Ended 2023-12-31 | $15.44B Ended 2023-12-29 |
| 3 years earlier | $6.70B Ended 2023-06-30 | $7.70B Ended 2023-02-03 | $4.20B Ended 2022-12-31 | $14.40B Ended 2022-12-30 |
| 4 years earlier | $6.20B Ended 2022-06-30 | $7.39B Ended 2022-01-28 | $3.66B Ended 2021-12-31 | $13.74B Ended 2021-12-31 |